Q4 2024 Earnings February 26, 2025 Call Participants Heather Rosentrater President and Chief Executive Officer Kevin Christie Senior VP, Chief Financial Officer, Treasurer, and Regulatory Affairs Officer 2 Forward-Looking Statements This presentation contains forward-looking statements, including statements regarding our current expectations for future financial performance and cash flows, capital expenditures, financing plans, our current plans or objectives for future operations and other factors, which m ...

Q4 2024 Earnings Call February 26, 2025 Forward Looking Statements and Disclaimers Please note that in this presentation the Company may discuss events or results that have not yet occurred or been realized, commonly referred to as forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of APi Group Corporation ("APi" or the "Company"). Such discussion and statements may contain words such as "expect," "antic ...

Trinity Capital Inc. (the "Company") cautions that this presentation may contain forward-looking statements that are based on current expectations and assumptions about future events, and which are not based in historical fact. The forward-looking statements in this presentation are based on current conditions as of the date of this presentation, and include, but are not limited to, statements regarding our financial objectives, beliefs, strategies, anticipated future operating results and cash flows, opera ...

EARNINGS SUPPLEMENTAL Q4 2024 FEBRUARY 2025 OVERVIEW | Key Statistics (1) (2) | | | --- | --- | | Properties | 95 | | Hotel Rooms | 21,156 | | Share Price | $10.21 | | Total Shares and Units Outstanding | 154.1 M | | Market Capitalization | $1.6 B | | Preferred Equity | $0.3 B | | Net Debt Outstanding | $1.8 B | | Total Enterprise Value (TEV) | $3.7 B | | Total Capitalization | $4.1 B | HOTEL TONNELLE NEW ORLEANS Debt Maturity Schedule (3) (1) For properties owned as of December 31, 2024; excludes Chateau L ...

Confidential & Proprietary – Do not distribute. © 2024 Zevia PBC 1 Q4 2024 FINANCIAL RESULTS Non-GAAP Financial Information Confidential & Proprietary – Do not distribute. © 2024 Zevia PBC 2 We use Adjusted EBITDA, a financial measure in this presentation and the related earnings press release that is not calculated in accordance with U.S. generally accepted accounting principles information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a ...

Investor Presentation FULL YEAR 2024 Such forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Many factors mentioned in "Item 1A. Risk Factors" of our most recent Annual Report on Form 10-K, as updated in subsequent filings with the SEC, will be important in determining future results. Should one or more of these risks or assumptions materialize, or should the underlying assumptions prove incorrect, actual results may vary materi ...

National Health Investors Q4 2024 Supplemental TABLE OF CONTENTS COMPANY | COMPANY INFORMATION & LEADERSHIP | 02 | | --- | --- | | PORTFOLIO | | | PORTFOLIO OVERVIEW | 03 | | REAL ESTATE INVESTMENTS | 04 | | SENIOR HOUSING OPERATING PORTFOLIO | 05 | | OPERATING PARTNERS | 06 | | EBITDARM LEASE COVERAGE & OCCUPANCY | 07 | | PURCHASE OPTIONS & LEASE MATURITIES | 08 | | INVESTMENTS | | | INVESTMENT RATIONALE | 09 | | RECENT INVESTMENTS | 10 | | CAPITALIZATION | | | CAPITALIZATION OVERVIEW | 11 | | CAPITAL STRU ...

4Q24 & FY24 Earnings Call This presentation was prepared by Ambev S.A. ("Ambev" or "Company") for the exclusive use in the earnings conference call of the fourth quarter and full year of 2024 (4Q24 and FY24). This presentation should not be considered as a complete document and should be analyzed together with the Company's financial statements (DFP) for the year and the respective press release, both available on the U.S. Securities and Exchange Commission – SEC and the CVM website. This presentation was p ...

These materials contain forward-looking information. Words such as "anticipate," "assume," "estimate," "expect," "target" "project," "model", "predict," "intend," "plan," "believe," "potential," "may," "should" and similar expressions may identify forward-looking information. Forward-looking information in these materials includes, but is not limited to, information regarding: First Quarter 2025 outlook, including revenue, adjusted EBITDA, adjusted EBITDA margin, and earnings per share and the drivers there ...

Rhythm Pharmaceuticals Fourth Quarter, Full Year 2024 Financial Results and Business Update February 26, 2025 ® © Rhythm® Pharmaceuticals, Inc. All rights reserved. On Today's Call ® ® 3 David Meeker, MD Chair, President and CEO ® 2 • David Connolly, Executive Director of Investor Relations and Corporate Communications • David Meeker, MD, Chair, President and Chief Executive Officer • Jennifer Lee, Executive Vice President, Head of North America • Yann Mazabraud, Executive Vice President, Head of Internatio ...